Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.37 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22631212 | 1.00 | FDPS (0.52) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL14646058 | 0.98 | FDPS (0.48) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL10242782 | 0.91 | FDPS (0.45) | FDPSCA2DNM1 | |
| SCHEMBL28183910 | 0.84 | LMNA (0.52) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL6229278 | 0.83 | FDPS (0.36) | FDPS | |
| SCHEMBL29174029 | 0.83 | FDPS (0.48) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL8415647 | 0.81 | FDPS (0.47) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL8415520 | 0.81 | FDPS (0.47) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL8416660 | 0.81 | FDPS (0.47) | FDPSLMNACA2GPR84SPHK1 | |
| SCHEMBL8415649 | 0.81 | FDPS (0.47) | FDPSLMNACA2GPR84SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4338592-A1 | USE OF COMPOUND FOR IMPROVING THE EFFICACY OF HERBICIDES | BASF SE (DE) | 2024-03-20 | — | — | EP | disclosed |
| CN-110612333-B | Polymer having branched structure | 巴斯夫欧洲公司 | 2022-05-24 | — | — | CN | disclosed |
| EP-2181593-B2 | Use of specific alcohol alkoxylates as adjuvant for the agrotechnical sector | BASF SE (DE) | 2022-02-23 | — | — | EP | disclosed |
| US-20200165368-A1 | POLYMER WITH BRANCHED STRUCTURE | BASF SE (DE) | 2020-05-28 | — | — | US | disclosed |
| EP-3622028-A1 | POLYMER WITH BRANCHED STRUCTURE | BASF SE (DE) | 2020-03-18 | — | — | EP | disclosed |
| CN-110612333-A | Polymer having branched structure | 巴斯夫欧洲公司 | 2019-12-24 | — | — | CN | disclosed |
| WO-2019185610-A1 | METHOD OF REDUCING SOIL WATER REPELLENCY | BASF SE (DE) | 2019-10-03 | — | — | WO | disclosed |
| WO-2019185612-A1 | METHOD OF REDUCING SOIL WATER REPELLENCY | BASF SE (DE) | 2019-10-03 | — | — | WO | disclosed |
| WO-2018206195-A1 | POLYMER WITH BRANCHED STRUCTURE | BASF SE (DE) | 2018-11-15 | — | — | WO | disclosed |
| WO-2018141913-A1 | METHODS TO ENHANCE SOIL WATER INFILTRATION AND TO REDUCE SOIL WATER REPELLENCY USING A SURFACTANT COMPOSITION | BASF SE (DE) | 2018-08-09 | — | — | WO | disclosed |
| EP-1656019-A1 | USE OF ALCOHOL-OXYALKYLATES IN THE FORM OF ADJUVANTS FOR BENZAMIDOXIME GUNGICIDAL DERIVATIVES, APPROPRIATE AGENTS AND KITS | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-17 | — | — | EP | disclosed |
| CN-1655674-A | Use of defined alcohol alkoxylates as adjuvants in the agrotechnical field | BASF AG (DE) | 2005-08-17 | — | — | CN | disclosed |
| US-20050170968-A1 | Accelerating plant uptake of active ingredients utilizing alkoxylated 2-propylheptanol | BASF SE (DE) | 2005-08-04 | — | — | US | disclosed |
| WO-2005015998-A1 | USE OF ALCOHOL-OXYALKYLATES IN THE FORM OF ADJUVANTS FOR BENZAMIDOXIME GUNGICIDAL DERIVATIVES, APPROPRIATE AGENTS AND KITS | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-24 | — | — | WO | disclosed |
| EP-1501355-A1 | USE OF DEFINED ALCOHOL ALKOXYLATES AS ADJUVANTS IN THE AGROTECHNICAL FIELD | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003090531-A1 | USE OF DEFINED ALCOHOL ALKOXYLATES AS ADJUVANTS IN THE AGROTECHNICAL FIELD | BASF AKTIENGESELLSCHAFT (DE) | 2003-11-06 | — | — | WO | disclosed |
| EP-0906150-B1 | ISO-TRIDECANOLALKOXYLATES IN BLOCK FORM AS LOW-FOAM OR ANTIFOAMING SURFACTANTS | BASF AG (DE) | 2000-08-23 | — | — | EP | disclosed |
| US-6057284-A | USE OF ISOTRIDECANOL BLOCK ALKOXYLATES HAVING AN ETHYLENE OXIDE BLOCK AND A PROPYLENE OXIDE OR BUTYLENE OXIDE BLOCK AS LOW FOAM OR FOAM SUPPRESSING SURFACTANS IN DETERGENT AND CLEANING FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-02 | — | — | US | disclosed |
| EP-0906150-A1 | ISO-TRIDECANOLALKOXYLATES IN BLOCK FORM AS LOW-FOAM OR ANTIFOAMING SURFACTANTS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997046311-A1 | ISO-TRIDECANOLALKOXYLATES IN BLOCK FORM AS LOW-FOAM OR ANTIFOAMING SURFACTANTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050170968-A1 | Accelerating plant uptake of active ingredients utilizing alkoxylated 2-propylheptanol | APEH, ADH5, ABHD5 | FDPS 1589/4885LMNA 2902/4885CA2 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.